Skip to main content

Lonza poised to mandate banks for specialty chemicals spinoff - sources

Swiss drug contract manufacturer Lonza is preparing to mandate banks for a stock market listing of its chemicals unit as it focuses on the faster-growing pharmaceutical and biotech companies business, two people close to the matter said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.